You can buy or sell Atreca and other stocks, options, ETFs, and crypto commission-free!
Atreca, Inc. Class A Common Stock, also called Atreca, is a biopharmaceutical company. Read More It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman in June 11, 2010 and is headquartered in Redwood, CA.
52 Week High
52 Week Low
-$0.57 per share